These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2819921)

  • 61. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 62. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.
    Kelly PH; Seviour PW; Iversen SD
    Brain Res; 1975 Sep; 94(3):507-22. PubMed ID: 1171714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neurotensin causes a greater increase in the metabolism of dopamine in the accumbens than in the striatum in vivo.
    Rivest R; Jolicoeur FB; Marsden CA
    Neuropharmacology; 1991 Jan; 30(1):25-33. PubMed ID: 2046877
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Induction of spermidine/spermine N1-acetyltransferase in rat tissues by polyamines.
    Pegg AE; Erwin BG
    Biochem J; 1985 Oct; 231(2):285-9. PubMed ID: 4062898
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats.
    Kelly PH; Iversen SD
    Eur J Pharmacol; 1976 Nov; 40(1):45-56. PubMed ID: 1033072
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors.
    Vasse M; Protais P
    Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
    Seeger TF; Thal L; Gardner EL
    Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Neurotensin effects on brain dopaminergic systems.
    Haubrich DR; Martin GE; Pflueger AB; Williams M
    Brain Res; 1982 Jan; 231(1):216-21. PubMed ID: 7198926
    [No Abstract]   [Full Text] [Related]  

  • 73. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system.
    Kalivas PW
    J Pharmacol Exp Ther; 1985 Nov; 235(2):544-50. PubMed ID: 4057084
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Substance P modulation of the mesolimbic dopamine system.
    Kalivas P
    Prog Clin Biol Res; 1985; 192():403-8. PubMed ID: 2417255
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multiple receptors for brain dopamine in behavior regulation: concept of dopamine-E and dopamine-I receptors.
    Cools AR; van Rossum JM
    Life Sci; 1980 Oct; 27(14):1237-53. PubMed ID: 6255271
    [No Abstract]   [Full Text] [Related]  

  • 76. Enhanced dopamine metabolism in accumbens leads to motor activity and concurrently to increased output from nondopamine neurons in ventral tegmental area and substantia nigra.
    Olds ME
    Physiol Behav; 1992 Jan; 51(1):39-50. PubMed ID: 1311110
    [TBL] [Abstract][Full Text] [Related]  

  • 77. S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
    Campbell A; Baldessarini RJ; Kula NS; Ram VJ; Neumeyer JL
    Brain Res; 1987 Feb; 403(2):393-7. PubMed ID: 3828830
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impairment of dopaminergic system function after chronic treatment with corticotropin-releasing factor.
    Izzo E; Sanna PP; Koob GF
    Pharmacol Biochem Behav; 2005 Aug; 81(4):701-8. PubMed ID: 16005056
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function.
    Jerussi TP; Glick SD
    Psychopharmacology (Berl); 1976 Jun; 47(3):249-60. PubMed ID: 823560
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of microinjection of 2-chloro-11 (2-dimethylaminoethoxy)-dibenzo[b,f]-thiepine (zotepine), thioridazine and haloperidol into the striatum and nucleus accumbens on stereotypic behaviour and motor activity.
    Lai H; Carino MA; Sperry R; Horita A
    J Pharm Pharmacol; 1981 Apr; 33(4):252-4. PubMed ID: 6115914
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.